Neuropsychiatric manifestations in systemic lupus erythematosus and the treatment of intrathecal methotrexate plus dexamethasone

National Medical Journal of China

Volumn 86, Issue 11, 2006, Pages 771-774

  Zhou, Hui Qiong ^a   Leng, Xiao Mei ^a   Zhang, Feng Chun ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Injections, spinal; Lupus erythematosus, systemic; Lupus vasculitis, central nervous system; Therapy

Indexed keywords

DEXAMETHASONE; METHOTREXATE;

ADULT; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEADACHE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; SEIZURE; SYSTEMIC LUPUS ERYTHEMATOSUS; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; CHILD; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; HEADACHE; HOSPITAL MORTALITY; HUMANS; INJECTIONS, SPINAL; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; METHOTREXATE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEIZURES; SURVIVAL RATE;

EID: 33646036698     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Hochberg MC. Updating the American Collage of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997, 40:1725.
2. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum, 1999, 42:599-608.
3. Bonbardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35:630-640.
4. Chinese source. 2003, 7:659-662.
5. Chinese source. 2004, 8:230-233.
6. Mok CC, Lau CS, Wong RWS. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol, 2001, 28:766-771.
7. Sanna G, Bertolaccini ML, Cuadrado MJ, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: Prevalence and association with antiphospholipid antibodies. J Rheumatol, 2003, 30:985-992.
8. Chinese source. 1994,16:277-280.
9. Valesini G, Priori R, Francis A, et al. Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotremate. Springer Semin Immunopathol, 1994, 16:313-321.
10. Chinese source. 2001,5:220-222.
11. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology (Oxford), 2002, 41:619-630.
12. Chinese source. 2002,6:437-438.